Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

China Gender-affirming Hormone Therapy Study in Transgender Men and Women

NCT05318755 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05318755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05318755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
China Gender-affirming Hormone Therapy Study in Transgender Men and Women
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 16, 2022
Completion date
December 31, 2028
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gender incongruence, transgender